$ESGH
ESG Inc.

2022 Q4 Form 10-K Financial Statement

#000152013822000523 Filed on November 17, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2022
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $10.00K $0.00 $50.00K
YoY Change -50.0%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $65.00 $0.00 $260.00
YoY Change 0.0%
% of Gross Profit
Operating Expenses $7.500K $0.00 $54.95K
YoY Change -66.47% 3684.64%
Operating Profit -$7.500K -$54.95K
YoY Change -66.47% 3684.64%
Interest Expense $0.00 $0.00 $0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net $0.00
YoY Change
Pretax Income -$7.491K $0.00 -$54.91K
YoY Change -66.51% 3681.89%
Income Tax
% Of Pretax Income
Net Earnings -$7.491K $0.00 -$54.91K
YoY Change -66.51% 3681.89%
Net Earnings / Revenue
Basic Earnings Per Share $0.00
Diluted Earnings Per Share $0.00 $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 15.47M shares 15.47M shares 15.47M shares
Diluted Shares Outstanding 15.47M shares

Balance Sheet

Concept 2022 Q4 2022 Q3 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $80.00K $90.00K $90.00K
YoY Change -33.33% -30.77%
Cash & Equivalents $80.78K $86.14K $90.00K
Short-Term Investments
Other Short-Term Assets $0.00 $0.00 $0.00
YoY Change -100.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $80.78K $86.14K $90.00K
YoY Change -32.68% -37.85% -35.71%
LONG-TERM ASSETS
Property, Plant & Equipment $964.00 $1.029K $0.00
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $964.00 $1.029K $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $80.78K $86.14K $90.00K
Total Long-Term Assets $964.00 $1.029K $0.00
Total Assets $81.75K $87.17K $90.00K
YoY Change -31.88% -37.11% -35.71%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.434K $3.366K $0.00
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $5.434K $3.366K $0.00
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $0.00
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $5.434K $3.366K $0.00
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $5.434K $3.366K $0.00
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$63.86K -$56.37K
YoY Change 3781.89%
Common Stock $15.47K $15.47K
YoY Change 0.72%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $76.31K $83.80K $80.00K
YoY Change
Total Liabilities & Shareholders Equity $81.75K $87.17K $90.00K
YoY Change -31.88% -37.11% -35.71%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2022
OPERATING ACTIVITIES
Net Income -$7.491K $0.00 -$54.91K
YoY Change -66.51% 3681.89%
Depreciation, Depletion And Amortization $65.00 $0.00 $260.00
YoY Change 0.0%
Cash From Operating Activities -$5.358K $0.00 -$40.18K
YoY Change -52.6% 224.1%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $1.289K
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 -$1.289K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change -100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000
YoY Change
NET CHANGE
Cash From Operating Activities -$5.358K 0.000 -$40.18K
Cash From Investing Activities 0.000 -$1.289K
Cash From Financing Activities 0.000 0.000
Net Change In Cash -$5.358K 0.000 -$41.47K
YoY Change -57.07% -132.5%
FREE CASH FLOW
Cash From Operating Activities -$5.358K $0.00 -$40.18K
Capital Expenditures $0.00 $1.289K
Free Cash Flow -$5.358K $0.00 -$41.47K
YoY Change -57.45% 234.5%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021 us-gaap Interest And Other Income
InterestAndOtherIncome
usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
usd
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
usd
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001883835
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
usd
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
usd
CY2021Q3 us-gaap Liabilities
Liabilities
usd
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
usd
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2021 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-08-31
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--08-31
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
333-259772
CY2022 dei Entity Registrant Name
EntityRegistrantName
PLASMA INNOVATIVE INC
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-1918342
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
523 School House Rd.
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Kennett Square
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
PA
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
19348
CY2022 dei City Area Code
CityAreaCode
267
CY2022 dei Local Phone Number
LocalPhoneNumber
467-5871
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022Q1 dei Entity Public Float
EntityPublicFloat
0 usd
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
15466668 shares
CY2022 dei Auditor Firm
AuditorFirmId
321
CY2022 dei Auditor Location
AuditorLocation
Brooklyn, NY
CY2022 dei Auditor Name
AuditorName
Jack Shama, CPA
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
86139 usd
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
127604 usd
CY2021Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
11000 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
86139 usd
CY2021Q3 us-gaap Assets Current
AssetsCurrent
138604 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1029 usd
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
-0 usd
CY2022Q3 us-gaap Assets
Assets
87168 usd
CY2021Q3 us-gaap Assets
Assets
138604 usd
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
3366 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
3366 usd
CY2022Q3 us-gaap Liabilities
Liabilities
3366 usd
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
65000000 shares
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
65000000 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15466668 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15466668 shares
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15466668 shares
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15466668 shares
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
15467 usd
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
15356 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
124700 usd
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
124700 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-56365 usd
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1452 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
83802 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
138604 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
87168 usd
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
138604 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
54953 usd
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1452 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
54953 usd
CY2021 us-gaap Operating Expenses
OperatingExpenses
1452 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-54953 usd
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-1452 usd
CY2022 us-gaap Interest And Other Income
InterestAndOtherIncome
40 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-54913 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1452 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-54913 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-1452 usd
CY2022 pmin Net Loss Per Share Basic And Diluted
NetLossPerShareBasicAndDiluted
-0.00
CY2021 pmin Net Loss Per Share Basic And Diluted
NetLossPerShareBasicAndDiluted
-0.00
CY2022 pmin Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
15466668 shares
CY2021 pmin Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
8124723 shares
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
10000 usd
CY2021 pmin Shares Issued For Intangible Assets
SharesIssuedForIntangibleAssets
56 usd
CY2021 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
130000 usd
CY2021 us-gaap Profit Loss
ProfitLoss
-1452 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
138604 usd
CY2022 pmin Shares Issued For Intangible Assets
SharesIssuedForIntangibleAssets
111 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-54913 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
83802 usd
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
54913 usd
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1452 usd
CY2022 pmin Shares Issued For Director Compensations
SharesIssuedForDirectorCompensations
111 usd
CY2021 pmin Shares Issued For Director Compensations
SharesIssuedForDirectorCompensations
56 usd
CY2022 pmin Payable To Reimbursement
PayableToReimbursement
3366 usd
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
260 usd
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-11000 usd
CY2021 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
11000 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-40176 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12396 usd
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1289 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1289 usd
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
140000 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
140000 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-41465 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
127604 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
127604 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
86139 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
127604 usd
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84F_eus-gaap--UseOfEstimates_zT7ZafsPBKMj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_864_z7XmFvvryXS8">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amount of revenues and expenses during the reporting period. Although these estimates are based on management’s knowledge of current events and actions management may undertake in the future, actual results may ultimately differ from those estimates and such differences may be material to our consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p>
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
86139 usd
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
127604 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1029 usd
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
0 usd
CY2022 us-gaap Depreciation
Depreciation
260 usd
CY2021 us-gaap Depreciation
Depreciation
0 usd
CY2022 us-gaap Revenue Recognition Deferred Revenue
RevenueRecognitionDeferredRevenue
<p id="xdx_843_eus-gaap--RevenueRecognitionDeferredRevenue_zzTbMNGZ5W37" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_86E_zbCYsT88f1Ji">Revenue Recognition</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company will recognize revenue in accordance with ASC Topic 606 “Revenue Recognition”. The Company recognizes revenue when products are fully delivered, or services have been provided and collection is reasonably assured.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p>
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
65000000 shares
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15466668 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15466668 shares

Files In Submission

Name View Source Status
0001520138-22-000523-index-headers.html Edgar Link pending
0001520138-22-000523-index.html Edgar Link pending
0001520138-22-000523.txt Edgar Link pending
0001520138-22-000523-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
img_001.jpg Edgar Link pending
img_002.jpg Edgar Link pending
img_003.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
pmin-20220831.xsd Edgar Link pending
pmin-20220831_10k.htm Edgar Link pending
pmin-20220831_ex31z1.htm Edgar Link pending
pmin-20220831_ex32z1.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
pmin-20220831_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
pmin-20220831_def.xml Edgar Link unprocessable
pmin-20220831_lab.xml Edgar Link unprocessable
pmin-20220831_pre.xml Edgar Link unprocessable
pmin-20220831_10k_htm.xml Edgar Link completed
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending